← All Sponsors
SPONSOR

Elixiron Immunotherapeutics (Hong Kong) Ltd.

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Non-segmental Vitiligo
NCT07223229 Phase 2
Recruiting

Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients

Non-segmental Vitiligo
United States, Taiwan View Trial →